Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study

被引:91
作者
Stenestrand, U [1 ]
Wallentin, L
机构
[1] Linkoping Univ Hosp, Dept Cardiol, SE-58185 Linkoping, Sweden
[2] Univ Uppsala Hosp, Dept Cardiol, Uppsala, Sweden
关键词
D O I
10.1016/S0140-6736(02)08710-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Randomised trials of early revascularisation in acute coronary syndromes have yielded conflicting results with respect to effects on survival. We assessed the association between revascularisation within 14 days after the index event and 1-year mortality in individuals who survived for at least 14 days after an acute myocardial infarction. Methods We studied a prospective cohort of patients admitted to the coronary care units of 61 Swedish hospitals between 1995 and 1998. We obtained 1-year mortality data from the Swedish National Cause of Death Register. We assessed 21912 individuals with first registry-recorded acute myocardial infarction, who were younger than age 80 years, and alive at day 14. Relative risk of 1-year mortality in patients who had revascularisation (n=2554) or those who did not (n=19 358) within 14 days was calculated by Cox regression analysis, adjusting for multiple covariates that affect mortality and with a propensity score that adjusted for covariates that affected the likelihood of early revascularisation. Findings At 1 year, unadjusted mortality was 9.0% (1751 deaths) in the conservative group and 3.3% (84 deaths) in the early revascularisation group. In the Cox regression analysis early revascularisation was associated with a reduction in 1-year mortality (relative risk 0.47; 95% CI 0.37-0.60; p<0.001). This relative reduction of mortality was similar in all subgroups irrespective of age, sex, baseline characteristics, previous disease manifestations, or treatment. Interpretation Early revascularisation in individuals with acute myocardial infarction is associated with substantial reduction in 1-year mortality. Our findings lend support to the use of an invasive approach early after an acute myocardial infarction.
引用
收藏
页码:1805 / 1811
页数:7
相关论文
共 30 条
[1]   10-YEAR FOLLOW-UP OF SURVIVAL AND MYOCARDIAL-INFARCTION IN THE RANDOMIZED CORONARY-ARTERY SURGERY STUDY [J].
ALDERMAN, EL ;
BOURASSA, MG ;
COHEN, LS ;
DAVIS, KB ;
KAISER, GG ;
KILLIP, T ;
MOCK, MB ;
PETTINGER, M ;
ROBERTSON, TL .
CIRCULATION, 1990, 82 (05) :1629-1646
[2]   ONE-YEAR RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) IIIB CLINICAL-TRIAL - A RANDOMIZED COMPARISON OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS PLACEBO AND EARLY INVASIVE VERSUS EARLY CONSERVATIVE STRATEGIES IN UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL-INFARCTION [J].
ANDERSON, HV ;
CANNON, CP ;
STONE, PH ;
WILLIAMS, DO ;
MCCABE, CH ;
KNATTERUD, GL ;
THOMPSON, B ;
WILLERSON, JT ;
BRAUNWALD, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (07) :1643-1650
[3]  
[Anonymous], 1989, NEW ENGL J MED, V320, P618
[4]  
Betriu A, 1997, NEW ENGL J MED, V336, P1621
[5]   Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy [J].
Boden, WE ;
O'Rourke, RA ;
Crawford, MH ;
Blaustein, AS ;
Deedwania, PC ;
Zoble, RG ;
Wexler, LF ;
Kleiger, RE ;
Pepine, CJ ;
Ferry, DR ;
Chow, BK ;
Lavori, PW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1785-1792
[6]   EVALUATION OF COMBINATION THROMBOLYTIC THERAPY AND TIMING OF CARDIAC-CATHETERIZATION IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION PHASE-5 RANDOMIZED TRIAL [J].
CALIFF, RM ;
TOPOL, EJ ;
STACK, RS ;
ELLIS, SG ;
GEORGE, BS ;
KEREIAKES, DJ ;
SAMAHA, JK ;
WORLEY, SJ ;
ANDERSON, JL ;
HARRELSONWOODLIEF, L ;
WALL, TC ;
PHILLIPS, HR ;
ABBOTTSMITH, CW ;
CANDELA, RJ ;
FLANAGAN, WH ;
SASAHARA, AA ;
MANTELL, SJ ;
LEE, KL .
CIRCULATION, 1991, 83 (05) :1543-1556
[7]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[8]  
Chamberlain DA, 1997, LANCET, V350, P461
[9]   Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America:: Results from the Platelet IIb/IIIa in Unstable Angina:: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial [J].
Cohen, MG ;
Pacchiana, CM ;
Corbalán, R ;
Perez, JEI ;
Ponte, CI ;
Oropeza, ES ;
Diaz, R ;
Paolasso, E ;
Izasa, D ;
Rodas, MA ;
Urrutia, CE ;
Harrington, RA ;
Topol, EJ ;
Califf, RM .
AMERICAN HEART JOURNAL, 2001, 141 (03) :391-401
[10]  
DEBONO DP, 1991, BMJ-BRIT MED J, V302, P555